Osaic Holdings’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Osaic Holdings’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,219	Closed	-$889	–	8147
2026 Q1	$889	Buy	+1,219	New	+$5.55K	﹤0.01%	7298
2024 Q4	–	Sell	-13	Closed	-$360	–	7597
2024 Q3	$360	Buy	13 +7	+117%	+$155	﹤0.01%	7070
2024 Q2	$160	Buy	+6	New	+$273	﹤0.01%	7193

Other funds holding RVPH

ECM

EMC Capital Management Houston, Texas $253M AUM

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

PUI

Purpose Unlimited Inc Toronto $2.62B AUM

MGI

Miller Global Investments Dallas, Texas $121M AUM

MWM

Mosley Wealth Management Anaheim, California $314M AUM

Osaic Holdings's RVPH Position: Q2 2026 in Review

Osaic Holdings sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 1,219 shares — an estimated $889 sold.

Osaic Holdings first reported a position in RVPH in Q2 2024 and held it in 3 quarters. The position peaked at $889 in Q1 2026. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

Osaic Holdings reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
Osaic Holdings sold 1,219 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $889.
Osaic Holdings first reported a position in REVIVA PHARMA HLDGS INC in Q2 2024 and held it in 3 quarters.
Osaic Holdings's REVIVA PHARMA HLDGS INC position peaked at $889 in Q1 2026.
5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.